GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice
Objective: Analogues of GDF15 (Growth Differentiation Factor 15) are promising new anti-obesity therapies as pharmacological treatment with GDF15 results in dramatic reductions of food intake and body weight. GDF15 exerts its central anorexic effects by binding to the GFRAL receptor exclusively expr...
Saved in:
Main Authors: | Henriette Frikke-Schmidt (Author), Karin Hultman (Author), Joseph W. Galaske (Author), Sebastian B. Jørgensen (Author), Martin G. Myers, Jr (Author), Randy J. Seeley (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2019-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weight Loss Induced by Bariatric Surgery Restricts Hepatic GDF15 Expression
by: Timon E. Adolph, et al.
Published: (2018) -
Exercise increases circulating GDF15 in humans
by: Maximilian Kleinert, et al.
Published: (2018) -
A long‐acting GDF15 analog causes robust, sustained weight loss and reduction of food intake in an obese nonhuman primate model
by: Songmao Zheng, et al.
Published: (2023) -
Role of GDF-15 as an inflammatory marker in patients with psoriasis vulgaris
by: Mustafa Kaan Taşolar, et al.
Published: (2021) -
Imperatorin ameliorates pulmonary fibrosis via GDF15 expression
by: Cheng-Fang Tsai, et al.
Published: (2023)